Form D · Biotechnology
AVIIR INC
Irvine, CA · CIK 0001380324
Offering snapshot reported Dec 21, 2011 · SEC filing
- Reported sold
- $10M Offering amount: $30M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 5, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 21, 2011 | Initial | $10,000,000 | No comparison | 6 | SEC filing |
| Dec 2, 2011 | Amendment | $3,750,000 | $750,000vs Jun 21, 2011 | 5 | SEC filing |
| Jun 21, 2011 | Initial | $3,000,000 | No comparison | 5 | SEC filing |
| Jan 19, 2010 | Initial | $4,200,000 | No comparison | 6 | SEC filing |
| Oct 20, 2009 | Initial | $1,000,000 | No comparison | 6 | SEC filing |
| Aug 7, 2009 | Initial | $1,000,000 | No comparison | 6 | SEC filing |
| Oct 10, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 20, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 25, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 17, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 6, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 25, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-170423
Sales of Series B Preferred Stock
Source: Form D, filed Dec 21, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John W. Campbell, Iii | Executive |
| Bill Gerber | Director |
| Douglas Harrington | Director, Executive |
| Paul Klingenstein | Director |
| Alex Komoroske | Director |
| Vijay Lathi | Director |
| Thomas Quertermous | Director |
| David Rubin | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9805 Research Drive
Irvine, CA, 92618
Irvine, CA, 92618